Health-Care

Health Care

The United States health care industry continues to face challenges arising from evolving government guidelines and increased government scrutiny of business practices. We have the experience necessary to help clients achieve their business goals in a manner that successfully navigates this evolving regulatory landscape. Our practice is national in scope and our clients range from start-up ventures to Fortune 20 corporations.

 
Regulatory Guidance

Our attorneys have significant experience in regulatory and compliance matters, including federal and state anti-kickback and anti-referral laws. Our areas of focus include guidance on appropriate structure of transactions and contractual arrangements to minimize fraud and abuse risk; guidance on implications of various sales and marketing practices and payments, including customer incentive and retention programs and physician office interactions; development of corporate compliance programs, policies, and codes of conduct; compliance training for in-house legal departments and their business counterparts; and internal compliance audits and guidance on the best manner to address audit findings.

 
Transactional Guidance

Our attention to detail and efficiency enables us to become trusted advisors to clients in the operational contracting that is necessary to allow their businesses to thrive. Clients have relied on us not only to develop and refine their contracting documents and models, but also to assume ongoing responsibility for day-to-day negotiation of their business contracts. Our areas of focus include pharmaceutical product purchase and distribution agreements; pharmaceutical product service agreements; PBM rebate agreements; GPO network contracting; clinical affiliation agreements; and payor contracting.

 

We also assist with corporate transactions and regulatory due diligence, where our deep industry knowledge enables us to provide excellent regulatory due diligence and identify risks that not only materially affect the valuation of the deal, but would also create significant post-closing liability.